Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Master Circulars issued thereunder, Indo US Bio Tech has informed that the Board of Directors of the Company at its meeting held on 16th June 2026, has considered and approved the following: 1. Noted the Resignation of Gautam N Associates, Chartered Accountants (FRN: 103117W), from the office of Statutory Auditor of the Company with effect from 15 June 2026. 2. Approved the Appointment of Bhagat & Associates, Chartered Accountants (FRN: 101100W), as Statutory Auditor of the Company with effect from 16th June 2026, subject to approval of the shareholders. 3. Noted the Resignation of Raj Shah & Co. (CA. Raj Shah) Proprietor (FRN: 141020W), (Membership Number: 166492) as Internal Auditor of the Company with effect from 15th June 2026. 4. Approved the appointment of J. M. Raval & Co. (CA J. M. RAVAL) Proprietor, (FRN: 123560W), Membership No.: 113830 as Internal Auditor of the Company with effect from 16t June 2026. The details as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBVHO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are enclosed as Annexure A. The Board Meeting commenced at 15:00 pm and concluded at 15:30 pm.
The above information is a part of company’s filings submitted to BSE.
